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Abstract  20 
Background/Objectives: The evidence for diet as a risk factor for multiple sclerosis (MS) is 21 
inconclusive. We examined the associations between fish consumption and risk of a first 22 
clinical diagnosis of central nervous system demyelination (FCD), a common precursor to 23 
MS. 24 
Methods: The 2003-2006 Ausimmune Study was a case-control study examining 25 
environmental risk factors for FCD, with participants recruited from four regions of Australia 26 
and matched on age, sex and study region. Dietary intake data were collected using a food 27 
frequency questionnaire. We used conditional logistic regression models to test associations 28 
between fish consumption (total, tinned, grilled, and fried) and risk of FCD (249 cases, 438 29 
controls), adjusting for history of infectious mononucleosis, smoking, serum 25-30 
hydroxyvitamin D concentrations, socioeconomic status, omega-3 supplement use, dietary 31 
under-reporting, and total energy intake. 32 
Results: Higher total fish consumption (per 30 g/day, equivalent to two serves/week) was 33 
associated with a 18% reduced risk of FCD (AOR 0.82; 95%CI 0.70, 0.97). While we found 34 
no statistically significant associations between grilled and fried fish consumption and risk of 35 
FCD, higher tinned fish consumption (per 30 g/day) was associated with a 41% reduced risk 36 
of FCD (AOR 0.59; 95% CI 0.39, 0.89).  37 
Conclusions: Tinned fish is predominantly oily, whereas grilled and fried fish are likely to be 38 
a combination of oily and white types. Oily fish is high in vitamin D and very long chain 39 
polyunsaturated omega-3 fatty acids, both of which may be beneficial in relation to MS.  40 
 41 
 42 
 43 
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Introduction 45 
 46 
Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the 47 
central nervous system (CNS) characterised by demyelination and episodes of neurological 48 
disability or progressive neurologic deterioration [1]. The disease affects more than two 49 
million people globally, and is two to three times more common in females than males. A 50 
number of genetic and environmental risk factors have been described, the latter including 51 
past history of infectious mononucleosis, adolescent obesity, low past sun exposure, smoking, 52 
and low vitamin D status [1]. By the time of peak MS risk – early to middle adulthood – very 53 
few of these risk factors are modifiable [2]. There is, however, some evidence to indicate that 54 
diet is a potentially modifiable risk factor for MS [3-9]. 55 
 56 
A number of studies have shown that oily fish consumption associates with reduced risk of 57 
MS [8, 10, 11]. Oily fish is the best natural source of both dietary vitamin D [12] and very 58 
long-chain omega-3 polyunsaturated fatty acids (VLCn3PUFAs) [13], both of which may 59 
have a beneficial role in MS. The association between vitamin D status and risk of MS is 60 
well-established [2], while VLCn3PUFAs - namely eicosapentaenoic acid (EPA), 61 
docosahexaenoic acid (DHA), and docosapentaenoic acid (DPA) - play critical roles in the 62 
central nervous system, exhibiting anti-inflammatory and neuro-protective effects [14]. 63 
 64 
The 2003-2006 Australian Multi-centre Study of Environment and Immune Function (the 65 
Ausimmune Study) [15] is a multicentre, incident case-control study investigating the 66 
environmental risk factors for a first clinical diagnosis of CNS demyelination (FCD), a 67 
common precursor to MS. The Ausimmune Study is one of the largest, most well-68 
characterised samples of people with early MS worldwide. Previously, higher vitamin D 69 
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status [16], higher VLCn3PUFA intakes (largely from fish, but also including small amounts 70 
from commonly-consumed meats, such as beef and ham) [17], a higher healthy dietary 71 
pattern score [9], and higher unprocessed red meat consumption [18] have been associated 72 
with reduced risk of FCD in the Ausimmune Study. We build on these studies by examining 73 
the associations between fish consumption and risk of FCD using data from the Ausimmune 74 
Study. 75 
 76 
Methods 77 
 78 
Study population 79 
Between November 2003 and December 2006, participants were recruited from four regions 80 
of Australia: Brisbane city, Newcastle region, Geelong and the Western districts of Victoria, 81 
and the island of Tasmania [15]. Case participants (n=282; 18-59 years) were referred to the 82 
study as previously described [15]. Following a full history and neurological examination, a 83 
study neurologist confirmed the date of onset and presenting symptoms suggestive of CNS 84 
demyelination [15]. Within the study period, case participants were diagnosed with CNS 85 
demyelination for the first time. The diagnoses included: a classic first demyelinating event 86 
(FDE; defined as a single, first, episode of clinical symptoms suggestive of CNS 87 
demyelination; n=216); a first recognised event, but past history revealed a prior, 88 
undiagnosed event, that, on review was highly suggestive of CNS demyelination (n=48); first 89 
presentation of primary progressive MS (based on neurological assessment on study entry 90 
(n=18)). It is unlikely that a prior unrecognised demyelinating event that had not been 91 
ascribed to CNS demyelination would have triggered any changes in dietary behaviour; thus 92 
these participants are considered to have an ‘incident’ FCD. The date of MRI scan, which 93 
was available for most participants, was use as a proxy for the date of FCD. There was a time 94 
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lag between the date of MRI scan by the neurologist (the date of the diagnosis which brought 95 
the participants into the study) and the study interview. For participants with dietary intake 96 
data, the median (interquartile range (IQR)) time lag was 101 (147) days. 97 
 98 
The Australian Electoral Roll (compulsory registration for citizens ≥18 years) was used to 99 
randomly select control participants (n=558) from the general population. Control 100 
participants were matched to case participants on age (within two years), sex and study 101 
region. Between one and four controls were matched to each case to maximise power, with 102 
more controls per case in regions with a lower expected number of cases due to being either 103 
at lower latitude (and lower expected incidence) or a smaller source population. Ethics 104 
approval was obtained from the nine Human Research Ethics Committees of the participating 105 
institutions [15]. All participants gave written informed consent for the use of their data. All 106 
participant information was anonymised and de-identified prior to analysis.  107 
 108 
Dietary assessment  109 
Information on habitual dietary intakes in the 12 months prior to the study interview was 110 
collected using the Cancer Council Victoria Dietary Questionnaire for Epidemiological 111 
Studies version 2 (DQESv2) [19]. The DQES v2 is a self-administered, semi-quantitative, 112 
food frequency questionnaire (FFQ) developed for use in the ethnically-diverse adult 113 
Australian population [20]. The consumption of food items from four food groups (cereals, 114 
sweets and snacks; dairy, meats and fish; fruit; vegetables) was recorded on a scale from 115 
“never” to “three or more times per day”. Portion size diagrams of four commonly consumed 116 
foods (potato, other vegetables, steak, casserole) were used to determine respondents’ 117 
average portion size factor, and responses were used to scale standard portion sizes up or 118 
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down for different foods [19]. Fish consumption (g/day) was reported for total (sum of 119 
tinned, grilled and fried fish), tinned, grilled and fried fish. 120 
 121 
Covariates 122 
Self-reported questionnaires were used to collect information on history of infectious 123 
mononucleosis (yes, no and don’t know), highest level of education (year 10 or less, year 12 124 
and Technical and Further Education, university), total number of years smoked minus any 125 
periods of absence. Socioeconomic status was assessed as quintiles of the Index of Relative 126 
Socio-economic Advantage and Disadvantage (IRSAD) using postal area code and data from 127 
the 2006 Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA), 128 
Australia [21]. IRSAD summarises information about the economic and social conditions of 129 
households within an area, including relative advantage and disadvantage measures: a low 130 
score indicates relatively greater disadvantage; a high score indicates greater advantage in 131 
general [21]. Supplement use was captured, as follows: “In the last 12 months, have you used 132 
any dietary or vitamin supplements on a regular basis?”. If yes, participants recorded the 133 
name, type, dose and frequency of use. Those who were using any fish oil, omega-3 or cod 134 
liver oil supplements were considered to be using an omega-3 supplement. 135 
 136 
A study nurse measured stature and weight. Basal metabolic rate (BMR) was calculated using 137 
the equations developed by Harris and Benedict [22]. Under-reporters were classified using a 138 
Goldberg cut-off below BMRx1.05 [23] and a two-category variable was defined: under-139 
reporter vs. plausible reporter. Most participants (94%) provided a blood sample: serum 140 
aliquots (1 mL) were stored at -80°C. Serum samples were analysed at study completion for 141 
25-hydroxyvitamin D (25(OH)D) concentrations using liquid chromatography tandem mass 142 
spectrometry [16]. Using the seasonal patterns, serum 25(OH)D concentrations for control 143 
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participants were adjusted to match the date of the case blood draw [16]. This was done to 144 
account for blood samples of cases and controls being taken at different times of the year. 145 
 146 
Statistical analysis 147 
Characteristics of participants were described as frequency and percentage for categorical 148 
variables, mean and standard deviation (SD) for continuous variables with a Normal 149 
distribution, and median and interquartile range (IQR) for continuous variables with a non-150 
Normal distribution.  151 
We used conditional logistic regression models (with cases and controls matched on age, sex 152 
and study region) to estimate odds ratios (ORs), 95% confidence intervals (95% CI) and p 153 
values for associations between fish consumption (total, tinned, grilled and fried) and risk of 154 
FCD. Fish consumption was analysed as a continuous variable per 30 g/day, to reflect a 155 
clinically relevant level of consumption (equivalent to approximately two serves/week). 156 
Model 1 was unadjusted; model 2 was adjusted for known environmental risk factors for MS 157 
(history of infectious mononucleosis, serum 25(OH)D concentrations, total years of 158 
smoking), along with socioeconomic status, omega-3 supplement use, dietary under-reporting 159 
and total energy intake.  160 
 161 
We tested for non-linearity using quadratic terms for total, tinned, grilled and fried fish 162 
consumption. To test for any sex differences, we included an interaction term for fish 163 
consumption and sex in the adjusted models. We conducted the following sensitivity 164 
analyses: a) within the smaller group of those with a classic FDE; and b) including only 165 
participants with plausible energy intakes (500-5000 kcal/day, based on a daily energy intake 166 
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associated with survival [23], which excludes those with extreme energy intakes as 167 
previously described [24, 25]).   168 
 169 
The Paramed command in Stata [26] was used to assess the potential mediating effects 170 
(natural indirect effect, NIE) of serum 25(OH)D concentrations on the relationship between 171 
fish consumption and risk of FCD, adjusting for the same environmental risk factors.  172 
Statistically, the NIE compares the risks of FCD when the values of the serum 25(OH)D 173 
concentrations vary from the one realised at fish consumption ≥ 30 g/day to the one realised 174 
at fish consumption < 30 g/day, assuming all relevant participants with fish consumption ≥ 30 175 
g/day.  The mediation analyses were performed for all participants, and further for the 176 
subgroup of people who had plausible energy intakes. Data were analysed using Stata 14 177 
software [27]. 178 
 179 
Results 180 
 181 
A total of 791 participants (272 cases, 519 controls) provided dietary intake data. Missing 182 
data for covariates were as follows: total years of smoking n=3; serum 25(OH)D 183 
concentrations, n=38; dietary misreporting, n=3; socioeconomic status, n=10. A total of 687 184 
participants (249 cases, 438 controls) provided complete data on dietary intake and all 185 
covariates, and were part of at least a matched control pair. As expected, case participants 186 
were more likely than controls to have a history of infectious mononucleosis, lower serum 187 
25(OH)D concentrations, and a greater total number of years of smoking (Table 1). Median 188 
total, tinned and grilled fish consumption were lower in case than control participants, while 189 
fried fish consumption was higher. Total fish consumption ≥30 g/day was reported by 40% of 190 
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participants (10, 12 and 3% of participants consumed ≥30 g/day tinned, grilled and fried fish, 191 
respectively).   192 
 193 
In adjusted models, higher total fish consumption (per 30 g/day, equivalent to two 194 
serves/week) was associated with a 18% reduced risk of FCD, and higher tinned fish 195 
consumption (per 30 g/day) was associated with a 41% reduced risk of FCD (Table 2). There 196 
were no statistically significant associations between grilled or fried fish consumption and 197 
risk of FCD (Table 2). The effect estimates for all models were similar when limited to those 198 
with plausible energy intakes and in the smaller subgroup of those with a classic FDE (Table 199 
2). There was no evidence of non-linearity in any models and no evidence of any interactions 200 
between fish consumption and sex. We found no evidence of statistically significant 201 
mediating effects of the serum 25(OH)D concentrations (total fish intake: NIE=1.00, 95%CI: 202 
0.94-1.05, p=0.846; tinned fish intake: NIE=0.99, 95%CI 0.89-1.09, p=0.808). The results 203 
were similar for the subgroup of people who had plausible energy intakes (total fish intake: 204 
NIE=1.00, 95%CI: 0.95-1.05, p=0.941; tinned fish intake: NIE=1.00, 95%CI: 0.92-1.08, 205 
p=0.918). 206 
 207 
Discussion 208 
 209 
Our results demonstrate an association between higher fish consumption and lower risk of 210 
FCD, particularly for tinned fish. An increment of two serves/week of tinned fish associated 211 
with approximately 40% reduced risk of FCD. Two serves of fish per week is in line with the 212 
Australian Dietary Guidelines (one serve = 100 g cooked fish fillet (115 g raw) or one small 213 
can of fish) [28]. Tinned fish is primarily oily fish (e.g. tuna, salmon, sardines, mackerel), 214 
which is the richest dietary source of both vitamin D [12] and VLCn3PUFAs [13]. We found 215 
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no association between consumption of grilled or fried fish and risk of FCD. Grilled fish is 216 
likely to include a combination of oily and white fish. The latter has lower levels of both 217 
vitamin D and VLCn3PUFAs than oily fish. Fried fish, particularly from take-away outlets, is 218 
likely to be white fish, again with lower levels of both vitamin D and VLCn3PUFAs than oily 219 
fish. 220 
 221 
Low vitamin D status is a known risk factor for MS [16]. The major source of vitamin D for 222 
humans is cutaneous synthesis from sun exposure; dietary intake of vitamin D becomes 223 
important when sun exposure is limited, with oily fish considered one of the best natural 224 
sources. However, in this study, we have not been able to demonstrate that serum 25(OH)D 225 
concentration is a significant mediator on the relationship between the fish consumption and 226 
the risk of FCD. This contradicts a previous hypothesis that intake of oily fish may 227 
compensate for vitamin D deficiency that is associated with increased MS risk [8].  228 
 229 
VLCn3PUFAs have been shown to suppress pro-inflammatory T-helper cells [29]; to inhibit 230 
the migration of T-helper cells across the blood brain barrier [30]; and to inhibit matrix 231 
metalloproteinases which are toxic to myelin [31]. DHA is a major constituent of neuronal 232 
membranes [32] and appears to play a role in synaptic signal transduction [33], while DPA is 233 
emerging as an important bioactive fatty acid, with a role in brain function and mental health 234 
[34]. Previous analysis of data from the Ausimmune Study showed a reduced risk of FCD 235 
with increasing intake of VLCn3PUFAs [17]. Furthermore, a small number of clinical trials 236 
have investigated the hypothesis that a higher intake of omega-3 fatty acids reduces disease 237 
activity in those with clinically diagnosed MS; however, the evidence is inconclusive [35-238 
37]. We were not able to test the mediating effects of VLCn3PUFAs due to the high uptake 239 
 11 
of fish oil supplements after FCD and the strong possibility of reverse causation in measuring 240 
VLCn3PUFAs in blood after diagnosis. 241 
 242 
Fish is also an important source of the sulfur-containing amino acid, taurine [38-40], which 243 
has therapeutic potential against neurological disorders [41]. Taurine has been shown to have 244 
anti-inflammatory and neuroprotective properties in a mouse Parkinson’s disease model [42], 245 
and has been identified as a dysregulated metabolite in animal models of MS, including in 246 
non-human primates [43]. Using a global metabolomics approach, taurine has also been 247 
shown to enhance remyelination through increasing differentiation of oligodendrocyte 248 
precursor cells. On the basis of these findings, the authors suggested that taurine 249 
supplementation, in combination with existing treatment strategies, could be a feasible 250 
strategy to improve remyelination [44]. To our knowledge, the role of taurine in MS risk has 251 
not been investigated. 252 
 253 
Our results concur with the few other studies investigating fish consumption and risk of MS. 254 
In a 2005-2012 population-based case-control study (1879 cases, 4135 controls) of incident 255 
MS in Sweden, participants were asked to specify how often, on average, they had eaten oily 256 
or white fish during the last five years [8]. Consumption of oily, but not white, fish was 257 
associated with decreased occurrence of MS. A case-control study conducted in Norway in 258 
2003 (152 cases, 402 controls) investigated sun exposure and dietary vitamin D in people 259 
with MS residing at latitudes above the Arctic Circle [10]. The results supported a protective 260 
effect of consuming boiled or fried fish (unspecified type) three or more times a week. In a 261 
case-control study of incident MS (197 cases, 202 age- and sex-matched controls) conducted 262 
between 1992 and 1995 in Montreal, Canada, dietary intake data were collected using a 164-263 
item food frequency questionnaire [11]. Fish consumption was protective in women only, 264 
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with borderline statistical significance; however, the type of fish consumed was unspecified 265 
and likely to reflect consumption of both oily and white fish.  266 
 267 
A major strength of the Ausimmune Study is its strong study design (multicentre, matched 268 
case-control), along with the recruitment of participants with an incident FCD (rather than 269 
participants with established MS). Although not all participants had a classic FDE during the 270 
study period, we performed sensitivity analyses in the smaller group of those with a classic 271 
FDE. Results were similar to the main models, albeit with wider confidence intervals. We 272 
used an established food frequency questionnaire to collect information on dietary intake 273 
over the previous 12 months, and we were able to account for a number of important 274 
potential confounders, including serum 25(OH)D concentrations measured by an accurate 275 
and reliable methodology [45].  276 
 277 
Although the widely-acknowledged under-reporting of energy intake [46] is a limitation of 278 
our study, we attempted to account for dietary under-reporting by adjusting for a 279 
misreporting variable. Further, we performed a sensitivity analysis including only 280 
participants with plausible energy intakes (500-5000 kcal/day), with minimal change in effect 281 
estimates compared with the main model. Although case participants may be more likely to 282 
recall exposure to risk factors than control participants [47], this bias is likely to be minimal 283 
in our study because diet is not commonly considered a cause of CNS demyelination. The 284 
association between higher fish consumption and reduced risk of FCD in our study may be 285 
due to lifestyle or environmental characteristics not captured in our analyses, and we cannot 286 
rule out the possibility of residual confounding. However, we adjusted for the main known 287 
environmental risk factors for MS. Other lifestyle characteristics, including current body 288 
mass index and physical activity, were not associated with risk of FCD in previous analysis 289 
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of the Ausimmune Study [48]. Since the study consisted of Australian participants who were 290 
predominantly Caucasian, the findings may not be generalisable to other populations with 291 
differing diets. 292 
 293 
Our results suggest a protective effect of higher fish consumption, particularly tinned (oily) 294 
fish consumption, on risk of FCD. The equivalent of two serves per week of tinned fish was 295 
associated with approximately 40% reduced risk of FCD. This level of fish consumption is in 296 
line with the Australian Dietary Guidelines. Given the higher levels of VLCn3PUFAs in oily 297 
fish compared with white fish, future studies would benefit from separating the consumption 298 
of these two types of fish. 299 
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Table 1. Characteristics of Ausimmune participants included in the current 
study (249 cases, 438 controls) 
  Case Control 
Sex,  n (%)1   
   Male 63 (25.3) 108 (24.7) 
   Female  186 (74.7) 330 (75.3) 
Age (years), mean (SD)1 38.7 (9.7) 40.0 (9.6) 
Study region, n (%)1   
   Brisbane (27°S) 83 (33.3) 159 (36.3) 
   Newcastle (33°S) 32 (12.9) 65 (14.8) 
   Geelong (37°S) 59 (23.7) 108 (24.7) 
   Tasmania (43°S) 75 (30.1) 106 (24.2) 
History of infectious mononucleosis, n (%)    
   No  163 (65.5) 345 (78.8) 
   Yes  70 (28.1) 71 (16.2) 
   Don’t know  16 (6.4) 22 (5.0) 
Serum 25(OH)D concentrations (nmol/L), mean 
(SD)  75.6 (29.5) 82.1 (30.4) 
Total years of smoking, median (IQR)  5.7 (18.6) 2 (14.8) 
Socioeconomic status,  n (%)   
   Quintile 1 (lowest) 28 (11.2) 57 (13.0) 
   Quintile 2 38 (15.3) 49 (11.2) 
   Quintile 3 43 (17.3) 103 (23.5) 
   Quintile 4 83 (33.3) 136 (31.1) 
   Quintile 5 (highest) 57 (22.9) 93 (21.2) 
Energy intake (kcal/day), median (IQR) 1658.4 (858.1) 
1743.9 
(894.4) 
Dietary misreporting,  n (%)   
   Under-reporter 106 (42.6) 176 (40.2) 
   Plausible reporter 143 (57.4) 262 (59.8) 
Fish consumption (g/day),  median (IQR)    
   Total fish 21.7 (28.1) 23.7 (30.0) 
   Tinned fish  4.7 (10.2) 6.6 (13.0) 
   Grilled fish  8.5 (14.2) 10.6 (16.1) 
   Fried fish 3.5 (8.6) 2.9 (8.2) 
SD, standard deviation; 25(OH)D, 25-hydroxyvitamin D; IQR, interquartile 
range 
 
 
 375 
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 376 
Table 2. Conditional logistic regression models showing associations between total, tinned, grilled and 
fried fish consumption and a) risk of FCD (249 cases, 438 controls); b) risk of true FDE (191 cases, 328 
controls); c) risk of FCD in those with plausible energy intakes (500-5000 kcal/day) (245 cases, 428 
controls) 
  Model 1: unadjusted   Model 2: adjusted1 
  OR (95% CI) P   AOR (95% CI) P 
a) risk of FCD      
Total fish, per 30 g/day 0.88 (0.76, 1.02) 0.088  0.82 (0.70, 0.97) 0.024 
Tinned fish, per 30 g/day 0.64 (0.44, 0.94) 0.022  0.59 (0.39, 0.89) 0.012 
Grilled fish, per 30 g/day 0.89 (0.71, 1.10) 0.284  0.83 (0.65, 1.07) 0.143 
Fried fish, per 30 g/day 0.84 (0.55, 1.28) 0.421  0.79 (0.49, 1.26) 0.321 
      
b) risk of FDE 
Total fish, per 30 g/day 0.92 (0.79, 1.08) 0.295  0.89 (0.73, 1.07) 0.208 
Tinned fish, per 30 g/day 0.71 (0.47, 1.09) 0.115  0.67 (0.42, 1.07) 0.096 
Grilled fish, per 30 g/day 0.92 (0.74, 1.14) 0.444  0.89 (0.68, 1.16) 0.389 
Fried fish, per 30 g/day 0.96 (0.60, 1.53) 0.87  0.96 (0.55, 1.69) 0.898 
      
c) risk of FCD in those with plausible energy intakes (500-5000 kcal/day)  
Total fish, per 30 g/day 0.87 (0.74, 1.02) 0.094  0.84 (0.70, 1.00) 0.054 
Tinned fish, per 30 g/day 0.66 (0.45, 0.97) 0.033  0.61 (0.40, 0.93) 0.023 
Grilled fish, per 30 g/day 0.90 (0.69, 1.18) 0.461  0.88 (0.65, 1.18) 0.385 
Fried fish, per 30 g/day 0.82 (0.51, 1.32) 0.415 		 0.76 (0.46, 1.28) 0.305 
377 
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